Andrew Bryan
Impact in
- Endocrinology top 1%
- Legionella and Acanthamoeba research
- Escherichia coli research studies
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 detection and testing 5
- Antifungal resistance and susceptibility 4
-
- Legionella and Acanthamoeba research 6
- Co-authors
- Nir Shapir (1 shared paper)Michael J. Sadowsky (1 shared paper)Mark H. Wener (6 shared papers)Chihiro Morishima (4 shared papers)Anu Chaudhary (3 shared papers)Susan L. Fink (4 shared papers)Michele S. Swanson (5 shared papers)Alexander L. Greninger (8 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Clinical Infectious Diseases (4 papers)Infection and Immunity (3 papers)Journal of Clinical Microbiology (3 papers)American Journal of Clinical Pathology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Andrew Bryan
41 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Endocrinology 311
- Molecular Medicine 223
- Infectious Diseases 587
- Pollution 139
- Applied Microbiology and Biotechnology 19
Countries citing papers authored by Andrew Bryan
This map shows the geographic impact of Andrew Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bryan more than expected).
Fields of papers citing papers by Andrew Bryan
This network shows the impact of papers produced by Andrew Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bryan. The network helps show where Andrew Bryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Bryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 366 | |
| 2 | 2004 | 235 | |
| 3 | 2010 | 184 | |
| 4 | 2018 | 105 | |
| 5 | 2019 | 81 | |
| 6 | 2006 | 72 | |
| 7 | 2020 | 57 | |
| 8 | 2021 | 29 | |
| 9 | 2020 | 26 | |
| 10 | 2019 | 26 | |
| 11 | 2022 | 25 | |
| 12 | 2023 | 21 | |
| 13 | 2020 | 21 | |
| 14 | 2021 | 18 | |
| 15 | 2011 | 18 | |
| 16 | 2011 | 18 | |
| 17 | 2020 | 18 | |
| 18 | 2013 | 16 | |
| 19 | 2016 | 12 | |
| 20 | 2021 | 12 |
About Andrew Bryan
Andrew Bryan is a scholar working on Infectious Diseases, Endocrinology, Epidemiology, Molecular Biology and Clinical Biochemistry, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (6 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 detection and testing (5 papers), Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antifungal resistance and susceptibility (4 papers), Biosensors and Analytical Detection (3 papers) and Bacterial biofilms and quorum sensing (3 papers). The work is most often cited by research in Endocrinology (311 citations), Molecular Medicine (223 citations), Infectious Diseases (587 citations), Pollution (139 citations) and Applied Microbiology and Biotechnology (19 citations). Andrew Bryan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Nir Shapir, Michael J. Sadowsky, Mark H. Wener, Chihiro Morishima, Anu Chaudhary, Susan L. Fink, Michele S. Swanson, Alexander L. Greninger, Patrick C. Mathias and Keith R. Jerome. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Infection and Immunity, Journal of Clinical Microbiology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.